Trials / Conditions / Premenstrual Dysphoric Disorder

Premenstrual Dysphoric Disorder

26 registered clinical trials studyying Premenstrual Dysphoric Disorder — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Emotion Regulation-based Internet-delivered Cognitive Behavioural Therapy for Premenstrual Dysphoric Disorder NCT06496139	Uppsala University	N/A
Active Not Recruiting	Adapting and Piloting Acceptance and Commitment Therapy (ACT) for Severe Premenstrual Mood Symptoms NCT06462391	Women's College Hospital	N/A
Recruiting	Pilot Study of the 'Thriving With PMDs' Program NCT06648382	University of Regina	N/A
Completed	The Effects of Mixhers HERTIME Supplements on Menstrual Symptoms NCT06136104	Midwestern University	N/A
Unknown	Combined Effect of Tryptophan Rich Diet and Acupuncture on Depression Related to Premenstrual Dysphoric Disord NCT05813366	Cairo University	N/A
Completed	Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder NCT05098574	St. Joseph's Healthcare Hamilton	Phase 2
Completed	Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25 NCT06227676	Cornell University	Phase 2 / Phase 3
Unknown	Premenstrual Dysphoric Disorder:Knowledge,Attitude and Practice Among Egyptian Females NCT05327075	Al-Azhar University	—
Withdrawn	EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders NCT04123483	Massachusetts General Hospital	Phase 4
Completed	Premenstrual Hormonal and Affective State Evaluation (PHASE) Project NCT03862469	University of Illinois at Chicago	N/A
Completed	Single Session of tACS in a Depressive Episode NCT03449979	University of North Carolina, Chapel Hill	N/A
Completed	A Study of Efficacy and Safety of Sepranolone (UC1010) in Patients With Premenstrual Dysphoric Disorder (PMDD) NCT03697265	Asarina Pharma	Phase 2
Unknown	Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder NCT01217775	Pherin Pharmaceuticals, Inc.	Phase 3
Completed	Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot Study NCT02508103	University of North Carolina, Chapel Hill	Phase 2 / Phase 3
Unknown	Deep Transcranial Magnetic Stimulation (dTMS) for the Treatment of Premenstrual Dysphoric Disorder (PMDD) NCT02448836	Tel-Aviv Sourasky Medical Center	N/A
Terminated	Targeting Inter-Hemispheric Alpha Coherence With tACS To Treat PMDD NCT02362191	University of North Carolina, Chapel Hill	N/A
Completed	Alternative Treatments for Premenstrual Dysphoric Disorder NCT01799733	University of California, San Diego	N/A
Completed	A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD) NCT01875718	Umecrine Mood AB	Phase 1 / Phase 2
Completed	The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels NCT01385709	Weill Medical College of Cornell University	—
Completed	Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD) NCT00927095	University of North Carolina, Chapel Hill	Phase 4
Completed	Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder NCT00536198	Yale University	Phase 4
Terminated	Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives NCT00089414	National Institute of Mental Health (NIMH)	Phase 2
Completed	Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD) NCT00518570	Berkshire Health Systems	N/A
Completed	A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria NCT00516113	Karolinska Institutet	Phase 4
Completed	The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder NCT00678574	University of Pennsylvania	Phase 4
Completed	Luteal Phase Administration of Paroxetine for the Treatment of PMDD NCT00620581	Hamilton Health Sciences Corporation	Phase 3